Curaleaf Holdings, Inc.
Join Class Action »
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Curaleaf Holdings, Inc. (OTC: CURLF) from November 21, 2018 through July 22, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Curaleaf investors under the federal securities laws.
If you bought Curaleaf securities between November 21, 2018 and July 22, 2019, and would like to join the action, please click “Join This Class Action,” above.
SHAREHOLDER ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Curaleaf Holdings, Inc. – CURLF
New York, N.Y., August 7, 2019. Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Curaleaf Holdings, Inc. (OTC: CURLF) from November 21, 2018 through July 22, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Curaleaf investors under the federal securities laws.
To join the Curaleaf class action, go to http://zhanginvestorlaw.com/cases/curaleaf-holdings-inc/ or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email firstname.lastname@example.org for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration (“FDA”); and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 4, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/curaleaf-holdings-inc/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at email@example.com.
Zhang Investor Law represents investors worldwide.